LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by date 2,442 pages found matching data breach- 8,500 Hip Implant Lawsuits Head to Trial this Month as MDL
Sep-12-16 Dallas, TX: The latest hip replacement litigation news is the DePuy Pinnacle trials, slated for late September in Dallas federal Court, Northern District. “This is the last big group of hip cases going to trial with the exception of Johnson & Johnson,” says attorney and practicing cardiologist Shezad Malik. “We are hopeful that a... - Trasylol: The Worm Turned Almost Overnight
Jan-27-08 Long Island, NY: By now most are familiar with the recent fortunes of anti-bleeding drug Trasylol , and how it has been pulled from world markets after studies have revealed links to heart attack, stroke and kidney failure . A major Canadian study was halted back in October after concern over the death rate of aprotinin (Trasylol) participants. The US Fo... - ENHANCE Test Results Show Zetia Does Not Reduce Artery Plaque
Jan-17-08 Dallas, TX: After a two-year delay, Merck/Schering-Plough Pharmaceuticals has released the ENHANCE test results for its controversial Vytorin combination drug. Vytorin combines Merck/Schering's Zetia and the statin drug Zocor (generic simvastatin). The tests showed that Vytorin performs no better than simvastatin alone in reducing plaque buildup in the a... - Statins Star Rises, But Zetia?
Jan-11-08 Kenilworth, NJ: The outlook on cholesterol-fighting statins only gets better, while cholesterol drug Zetia continues to be cloaked in a shroud of secrecy. At issue is a study on Zetia's safety and effectiveness that was completed two years ago by Merck and Schering-Plough, but was never released. The so-called Enhance study, which should give the best in... - Beaten Down: Nursing Home Abuse Citations on the Rise
Jan-9-08 Washington, DC: As an aging population puts a greater importance and strain on nursing homes, seniors residences and assisted living, concern is mounting over nursing home safety, and the apparent rise in nursing home abuse. Just prior to Christmas, it was revealed that serious reprimands for dangerous conditions at nursing homes had increased 22 per... - UK Regulator Investigating Trasylol, Pulls Licenses
Jan-8-08 Washington, DC: The future of Trasylol , the heart drug manufactured by Bayer AG, became even more clouded as the year prepared to come to a close, after the Commission on Human Medicines in the United Kingdom advised that the UK marketing authorizations for Trasylol should be pulled, and held in abeyance pending the outcome of a full, European review of... - Chantix by Pfizer: Quitting Smoking Could Kill You
Dec-23-07 Dallas, TX Trying to quit smoking is hard enough, without being driven to suicide. But that appears to be a possibility with Chantix, and its United Kingdom counterpart Champix, after reports of smoking cessation patients experiencing suicidal thoughts. The European Medical Agency (EMEA), which is responsible for regulating medicines in 27 countries ove... - Feds Considering Exemptions to Illegal RoboCall Rules
Aug-11-16 Washington, DC: You’ve heard it before: what the government giveth, the government taketh away. That’s the crux of a divergence of goals and protections that pit one arm of the federal government against the other in the name of collecting delinquent accounts. The result is a major crack in an armor intended to protect Americans already under s... - FDA's Refusal to Approve New Cancer Vaccine - The Plot Thickens - Part II
Nov-29-07 Washington, DC: On November 26, 2007, CareToLive, the non-profit corporation that is suing FDA officials on behalf of terminal prostate cancer patients over the decision not to approve Provenge, a new life-extending prostate cancer vaccine, announced that a judge had dismissed the lawsuit. Please click here for a free evaluation of your case The... - Avandia: A New Black Box Warning, and a Reprieve from the FDA
Nov-18-07 Washington, DC As some had predicted, GlaxoSmithKline caved to sustained pressure by the US Food and Drug Administration (FDA) and agreed to add a second black box warning for Avandia , the diabetes drug linked to increased risk of heart attack. However, the warning is somewhat watered-down, and in the absence of any unforeseen, blockbuster medical r... - Trasylol Kills: Somebody Tell Bayer and the FDA
Nov-13-07 Waltham, MA Two days after announcing that Trasylol was subject to a global recall over concern for continued risk of heart attack, kidney failure and death, Bayer AG quietly posted the final report on the study that got them into so much hot water 18 months ago. That study, conducted by i3 Drug Safety, an independent lab based in Waltham, Massachuset... - Stand 'n Seal: Seal Your Tile, Seal Your Fate...
Nov-11-07 Denville, NJ As lawsuits continue to circulate through the courts in the wake of the Stand 'n Seal dangerous product recall , more information is coming to light that casts an even darker shadow on the product, and the dubious efforts of the manufacturer and distributor to warn the public against a serious personal injury hazard. Perhaps most damning... - Bair Hugger Lawsuits Tip of the Iceberg
Jul-20-16 Baton Rouge, LA: The number of filings in multidistrict litigation over the Bair Hugger warming blanket greatly increased in June, according to a Reuters analysis of data from the US Judicial Panel on Multidistrict Litigation. While court documents haven’t disclosed how many Bair Hugger lawsuits are currently pending, the manufacturer, 3M... - Multidistrict Litigations Involving IVC Filters Continue to Grow
Jul-19-16 Phoenix, AZ: Two IVC filter multidistrict litigations continue to grow, as more lawsuits alleging serious complications linked to the filters have been filed. These complications reportedly include filter migration and perforation of blood vessels. In some cases, the inferior vena cava filters have been linked to patient death. The two multidistric... - How Deep Are the Risperdal Maker’s Pockets?
Jul-14-16 Philadelphia, PA: The Risperdal maker , Johnson & Johnson, was ordered July 1 to pay $70 million to a teenager who developed gynecomastia, which is the abnormal development of breasts in males. This latest lawsuit is surely a blow to the drug giant, especially because it is still facing more than 1,200 lawsuits nationwide, but mainly in Philadelphia... - IVC Filter Problems: Survivors Are Lucky…
Jul-11-16 Chicago, IL: As IVC filter lawsuits continue to climb, it is instructive to revisit the words of a noted interventional radiologist, from Stanford Health Care, who made damning comments late last year to NBC News (12/31/16) about the C. R. Bard inferior vena cava filter, and the impact it is having on patients. “All of the data that we&rsquo... - Transvaginal Mesh Warnings Added to Labels
Jul-5-16 Los Angeles, CA: One transvaginal mesh manufacturer is adding new safety labels to its pelvic meshes and slings, saying they are considered permanent implants and that removal can be complicated or impossible. Transvaginal mesh products have been used worldwide for about 15 years, mostly to treat pelvic organ prolapse (POP) and stress urinary incont... - Attorney Subpoenas J&J, AstraZeneca and Lilly for Hidden Antipsychotic Data Part I
Sep-10-07 Washington, DC Alaska attorney Jim Gottstein has issued subpoenas for the discovery of any suppressed data on the atypical antipsychotic drugs Zyprexa , Risperdal, and Seroquel which he says is necessary before a Forced Drugging Petition can possibly be considered for approval for a client he is representing. Mr Gottstein contends that the informatio... - SSRI-Induced Akathisia's Link To Suicide and Violence
Aug-18-07 Washington, DC: Medical experts have long known that the side effect associated with the class of antidepressants known as the selective serotonin reuptake inhibitors most likely to drive people to suicide or violence against others is "akathisia". Akathisia is but one in a long list of side effects that SSRI makers were able to keep hidden, as they set... - Overdraft Fees Still a Big Payday for Financial Institutions
Jun-18-16 Washington, DC : Despite rules meant to curb excessive overdraft fees , according to information from the Federal Deposit Insurance Corporation (FDIC), some consumers are still having a difficult time getting out of overdraft, given the high fees charged for each overdraft transaction. According to the FDIC report (as cited by The Washington Post ; 6/13...